The study results, published in the July 15, 2026, online edition of The Lancet Gastroenterology & Hepatology , address a major unmet need for people with metabolic dysfunctionassociated steatohepatitis (MASH), a serious form of fatty liver disease that can lead to cirrhosis, liver failure, and the need for transplantation
Without testosterone replacement, GLP-1 medications alone may cause 15-40% of weight loss to come from lean mass rather than fat
The most direct comparison to Wegovy comes from the SURMOUNT-5 trial, which put tirzepatide and semaglutide head-to-head for the first time
Future Directions: BPC 157 rapidly increases various genes expression in rat excision skin wound
This might be related to eating less or could be a direct effect of the medication
AgathocleousMMeachamCBurgessRPiskounovaEZhaoZCraneGet alAscorbate regulates haematopoietic stem cell function and leukaemogenesis